

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of histone deacetylation (GO:0031065) | 4.54683984 |
| 2 | maternal placenta development (GO:0001893) | 3.80101298 |
| 3 | regulation of cholesterol homeostasis (GO:2000188) | 3.78873629 |
| 4 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.77635865 |
| 5 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.77635865 |
| 6 | regulation of translational fidelity (GO:0006450) | 3.77161140 |
| 7 | negative regulation of cell size (GO:0045792) | 3.69852519 |
| 8 | low-density lipoprotein particle clearance (GO:0034383) | 3.52139466 |
| 9 | regulation of fatty acid beta-oxidation (GO:0031998) | 3.36842415 |
| 10 | response to peptidoglycan (GO:0032494) | 3.36796593 |
| 11 | protein localization to endosome (GO:0036010) | 3.30061449 |
| 12 | positive regulation by symbiont of host defense response (GO:0052509) | 3.27677067 |
| 13 | modulation by symbiont of host defense response (GO:0052031) | 3.27677067 |
| 14 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.27677067 |
| 15 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.27677067 |
| 16 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.27677067 |
| 17 | modulation by symbiont of host immune response (GO:0052553) | 3.27677067 |
| 18 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 3.26269554 |
| 19 | mitotic G1 DNA damage checkpoint (GO:0031571) | 3.26078339 |
| 20 | heterochromatin organization (GO:0070828) | 3.25682533 |
| 21 | positive regulation of protein deacetylation (GO:0090312) | 3.23493014 |
| 22 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.21265571 |
| 23 | apoptotic cell clearance (GO:0043277) | 3.20003623 |
| 24 | apoptotic process involved in morphogenesis (GO:0060561) | 3.14630370 |
| 25 | pre-miRNA processing (GO:0031054) | 3.12607565 |
| 26 | macrophage activation involved in immune response (GO:0002281) | 3.08596071 |
| 27 | regulation of translational termination (GO:0006449) | 3.05743915 |
| 28 | regulation of cholesterol storage (GO:0010885) | 3.05166126 |
| 29 | pentose-phosphate shunt (GO:0006098) | 3.04245474 |
| 30 | germinal center formation (GO:0002467) | 3.02827756 |
| 31 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.99899546 |
| 32 | response to muramyl dipeptide (GO:0032495) | 2.99586623 |
| 33 | modulation by symbiont of host cellular process (GO:0044068) | 2.98058529 |
| 34 | adherens junction assembly (GO:0034333) | 2.96292151 |
| 35 | cell-substrate junction assembly (GO:0007044) | 2.96003758 |
| 36 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 2.95789838 |
| 37 | detection of other organism (GO:0098543) | 2.94926489 |
| 38 | positive regulation of triglyceride biosynthetic process (GO:0010867) | 2.94758903 |
| 39 | regulation of hippo signaling (GO:0035330) | 2.94266725 |
| 40 | mitotic G1/S transition checkpoint (GO:0044819) | 2.94082351 |
| 41 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 2.93917859 |
| 42 | barbed-end actin filament capping (GO:0051016) | 2.92978657 |
| 43 | response to laminar fluid shear stress (GO:0034616) | 2.92484217 |
| 44 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.91627666 |
| 45 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.90610221 |
| 46 | peptidyl-lysine dimethylation (GO:0018027) | 2.90266139 |
| 47 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.86607367 |
| 48 | positive regulation of nuclease activity (GO:0032075) | 2.85877120 |
| 49 | detection of bacterium (GO:0016045) | 2.84946957 |
| 50 | cell-substrate adherens junction assembly (GO:0007045) | 2.82714997 |
| 51 | focal adhesion assembly (GO:0048041) | 2.82714997 |
| 52 | G1 DNA damage checkpoint (GO:0044783) | 2.82468816 |
| 53 | amyloid precursor protein catabolic process (GO:0042987) | 2.79559846 |
| 54 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.79245193 |
| 55 | regulation of chromatin binding (GO:0035561) | 2.79222166 |
| 56 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.77446875 |
| 57 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.77317418 |
| 58 | RNA stabilization (GO:0043489) | 2.76971041 |
| 59 | mRNA stabilization (GO:0048255) | 2.76971041 |
| 60 | regulation of extracellular matrix disassembly (GO:0010715) | 2.75417999 |
| 61 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.72074748 |
| 62 | regulation of leukocyte degranulation (GO:0043300) | 2.69781664 |
| 63 | natural killer cell differentiation (GO:0001779) | 2.69709128 |
| 64 | 4-hydroxyproline metabolic process (GO:0019471) | 2.69068903 |
| 65 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.66013574 |
| 66 | modulation by virus of host process (GO:0019054) | 2.65579538 |
| 67 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 2.64875092 |
| 68 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 2.64199598 |
| 69 | NADPH regeneration (GO:0006740) | 2.62743982 |
| 70 | regulation of NFAT protein import into nucleus (GO:0051532) | 2.60856293 |
| 71 | growth hormone receptor signaling pathway (GO:0060396) | 2.60724314 |
| 72 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.60665851 |
| 73 | detection of external biotic stimulus (GO:0098581) | 2.60004177 |
| 74 | regulation of ARF protein signal transduction (GO:0032012) | 2.59032385 |
| 75 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.58938275 |
| 76 | cytoplasmic mRNA processing body assembly (GO:0033962) | 2.58607886 |
| 77 | regulation of gamma-delta T cell activation (GO:0046643) | 2.58459980 |
| 78 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.57694403 |
| 79 | detection of molecule of bacterial origin (GO:0032490) | 2.57644114 |
| 80 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.56650500 |
| 81 | regulation of nuclease activity (GO:0032069) | 2.56205396 |
| 82 | embryonic process involved in female pregnancy (GO:0060136) | 2.55874527 |
| 83 | alpha-linolenic acid metabolic process (GO:0036109) | 2.55241488 |
| 84 | COPI coating of Golgi vesicle (GO:0048205) | 2.54753870 |
| 85 | Golgi transport vesicle coating (GO:0048200) | 2.54753870 |
| 86 | pinocytosis (GO:0006907) | 2.54431755 |
| 87 | regulation of early endosome to late endosome transport (GO:2000641) | 2.54046059 |
| 88 | positive regulation of triglyceride metabolic process (GO:0090208) | 2.53566588 |
| 89 | negative regulation of lipid transport (GO:0032369) | 2.53428407 |
| 90 | positive thymic T cell selection (GO:0045059) | 2.53417900 |
| 91 | sexual reproduction (GO:0019953) | 2.52730954 |
| 92 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 2.52646998 |
| 93 | regulation of ARF GTPase activity (GO:0032312) | 2.51882193 |
| 94 | negative regulation of cell killing (GO:0031342) | 2.51576878 |
| 95 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.51576878 |
| 96 | receptor catabolic process (GO:0032801) | 2.50531700 |
| 97 | stress fiber assembly (GO:0043149) | 2.49587654 |
| 98 | NLS-bearing protein import into nucleus (GO:0006607) | 2.49535469 |
| 99 | plasma membrane repair (GO:0001778) | 2.49471985 |
| 100 | chromatin assembly (GO:0031497) | 2.48818066 |
| 101 | negative regulation of nucleotide catabolic process (GO:0030812) | 2.48657386 |
| 102 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.48550415 |
| 103 | intracellular estrogen receptor signaling pathway (GO:0030520) | 2.48524280 |
| 104 | NIK/NF-kappaB signaling (GO:0038061) | 2.48148275 |
| 105 | trophectodermal cell differentiation (GO:0001829) | 2.46841482 |
| 106 | positive regulation of receptor recycling (GO:0001921) | 2.46058666 |
| 107 | negative regulation of cholesterol transport (GO:0032375) | 2.45292188 |
| 108 | negative regulation of sterol transport (GO:0032372) | 2.45292188 |
| 109 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.44976537 |
| 110 | activation of JUN kinase activity (GO:0007257) | 2.44827997 |
| 111 | semaphorin-plexin signaling pathway (GO:0071526) | 2.43316300 |
| 112 | negative regulation of heart growth (GO:0061117) | 2.42972187 |
| 113 | negative regulation of cardiac muscle tissue growth (GO:0055022) | 2.42972187 |
| 114 | cortical actin cytoskeleton organization (GO:0030866) | 2.42818497 |
| 115 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.41463267 |
| 116 | negative regulation of interleukin-12 production (GO:0032695) | 2.40069194 |
| 117 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.39855675 |
| 118 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.37887485 |
| 119 | regulation of mast cell degranulation (GO:0043304) | 2.37700566 |
| 120 | endoplasmic reticulum unfolded protein response (GO:0030968) | 2.37474220 |
| 121 | labyrinthine layer blood vessel development (GO:0060716) | 2.37471762 |
| 122 | endothelial cell chemotaxis (GO:0035767) | 2.37306064 |
| 123 | detection of biotic stimulus (GO:0009595) | 2.36685442 |
| 124 | neutrophil activation involved in immune response (GO:0002283) | 2.36210975 |
| 125 | morphogenesis of an endothelium (GO:0003159) | 2.34753700 |
| 126 | endothelial tube morphogenesis (GO:0061154) | 2.34753700 |
| 127 | regulation of p38MAPK cascade (GO:1900744) | 2.34669155 |
| 128 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.34138361 |
| 129 | positive regulation of p38MAPK cascade (GO:1900745) | 2.33038467 |
| 130 | negative regulation of fatty acid transport (GO:2000192) | 2.32260357 |
| 131 | L-alpha-amino acid transmembrane transport (GO:1902475) | 2.31975402 |
| 132 | thymic T cell selection (GO:0045061) | 2.31287019 |
| 133 | protein-lipid complex assembly (GO:0065005) | 2.31176132 |
| 134 | sulfur amino acid catabolic process (GO:0000098) | 2.30204239 |
| 135 | establishment of apical/basal cell polarity (GO:0035089) | 2.30007835 |
| 136 | leukocyte aggregation (GO:0070486) | 2.29295036 |
| 137 | mannose metabolic process (GO:0006013) | 2.29135050 |
| 138 | cell-cell junction maintenance (GO:0045217) | 2.28270822 |
| 139 | activation of MAPKKK activity (GO:0000185) | 2.26908166 |
| 140 | regulation of lipid kinase activity (GO:0043550) | 2.26626056 |
| 141 | cellular response to virus (GO:0098586) | 2.25735866 |
| 142 | plasma lipoprotein particle clearance (GO:0034381) | 2.25007734 |
| 143 | 2-oxoglutarate metabolic process (GO:0006103) | 2.24793585 |
| 144 | regulation of regulated secretory pathway (GO:1903305) | 2.23558142 |
| 145 | cellular response to unfolded protein (GO:0034620) | 2.23325848 |
| 146 | epithelial cell-cell adhesion (GO:0090136) | 2.23222906 |
| 147 | activation of Rac GTPase activity (GO:0032863) | 2.23093500 |
| 148 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.22349149 |
| 149 | positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:00360 | 2.21362761 |
| 150 | regulation of glucose import in response to insulin stimulus (GO:2001273) | 2.20885352 |
| 151 | regulation of phosphatidylinositol 3-kinase activity (GO:0043551) | 2.20648133 |
| 152 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.20589663 |
| 153 | hemidesmosome assembly (GO:0031581) | 2.20321033 |
| 154 | protein localization to kinetochore (GO:0034501) | 2.20200943 |
| 155 | response to host (GO:0075136) | 2.19779461 |
| 156 | response to host defenses (GO:0052200) | 2.19779461 |
| 157 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.19779461 |
| 158 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.19220410 |
| 159 | positive regulation of Rap GTPase activity (GO:0032854) | 2.16901198 |
| 160 | immunoglobulin mediated immune response (GO:0016064) | 2.15698895 |
| 161 | positive regulation of blood vessel endothelial cell migration (GO:0043536) | 2.15473624 |
| 162 | regulation of macrophage cytokine production (GO:0010935) | 2.15218664 |
| 163 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.14694763 |
| 164 | skin morphogenesis (GO:0043589) | 2.14628676 |
| 165 | regulation of defense response to virus by virus (GO:0050690) | 2.14475939 |
| 166 | regulation of necroptotic process (GO:0060544) | 2.13658869 |
| 167 | response to fluid shear stress (GO:0034405) | 2.13605951 |
| 168 | positive regulation of type 2 immune response (GO:0002830) | 2.13068397 |
| 169 | amyloid precursor protein metabolic process (GO:0042982) | 2.12769378 |
| 170 | signal complex assembly (GO:0007172) | 2.11738366 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.31210628 |
| 2 | MYC_22102868_ChIP-Seq_BL_Human | 3.17295178 |
| 3 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.67821399 |
| 4 | * VDR_21846776_ChIP-Seq_THP-1_Human | 2.63168538 |
| 5 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.53969458 |
| 6 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.49576051 |
| 7 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.46518195 |
| 8 | KDM2B_26808549_Chip-Seq_DND41_Human | 2.43403173 |
| 9 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.40730991 |
| 10 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.35262475 |
| 11 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.32060539 |
| 12 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.30097816 |
| 13 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 2.27371111 |
| 14 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.21589530 |
| 15 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 2.16028633 |
| 16 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.15647573 |
| 17 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.10793049 |
| 18 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 2.09324686 |
| 19 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.07781948 |
| 20 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.99704953 |
| 21 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.91536325 |
| 22 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.86173084 |
| 23 | MAF_26560356_Chip-Seq_TH1_Human | 1.83829410 |
| 24 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.78759223 |
| 25 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.72256602 |
| 26 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.67818762 |
| 27 | UTX_26944678_Chip-Seq_JUKART_Human | 1.66855478 |
| 28 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.66289013 |
| 29 | KDM2B_26808549_Chip-Seq_K562_Human | 1.66265699 |
| 30 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.62576750 |
| 31 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.61133011 |
| 32 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.59030039 |
| 33 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.58902655 |
| 34 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.58869452 |
| 35 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.55651459 |
| 36 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.55540534 |
| 37 | ATF3_27146783_Chip-Seq_COLON_Human | 1.54719115 |
| 38 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.54437521 |
| 39 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.54272768 |
| 40 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.54056321 |
| 41 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.53529591 |
| 42 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.50004695 |
| 43 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.46286141 |
| 44 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.46071413 |
| 45 | * VDR_24763502_ChIP-Seq_THP-1_Human | 1.43718200 |
| 46 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.43371787 |
| 47 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.42419091 |
| 48 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.42397527 |
| 49 | * RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.41685332 |
| 50 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.39503706 |
| 51 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.37551440 |
| 52 | P68_20966046_ChIP-Seq_HELA_Human | 1.37540321 |
| 53 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.36562884 |
| 54 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.36266674 |
| 55 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.32608371 |
| 56 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.32488408 |
| 57 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.32239563 |
| 58 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.30809869 |
| 59 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 1.30477412 |
| 60 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.28702021 |
| 61 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.28583667 |
| 62 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.27360310 |
| 63 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.27336211 |
| 64 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.25758205 |
| 65 | MAF_26560356_Chip-Seq_TH2_Human | 1.25304226 |
| 66 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.25271380 |
| 67 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.25030523 |
| 68 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.24533992 |
| 69 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.24523793 |
| 70 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.24026275 |
| 71 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.23133243 |
| 72 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.20923619 |
| 73 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.20785403 |
| 74 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.20590977 |
| 75 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.19558461 |
| 76 | GATA1_19941826_ChIP-Seq_K562_Human | 1.19310141 |
| 77 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.18597715 |
| 78 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.18203871 |
| 79 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.18118927 |
| 80 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.17985775 |
| 81 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.16290916 |
| 82 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.16181383 |
| 83 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.15031519 |
| 84 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.13546208 |
| 85 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.12993300 |
| 86 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.12861949 |
| 87 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.12791589 |
| 88 | SPI1_23127762_ChIP-Seq_K562_Human | 1.12702313 |
| 89 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.11662236 |
| 90 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.10301293 |
| 91 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.10033836 |
| 92 | * SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.09978382 |
| 93 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.09275263 |
| 94 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.09161528 |
| 95 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.08849188 |
| 96 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.08118878 |
| 97 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.07171817 |
| 98 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.07047223 |
| 99 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.06928786 |
| 100 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.06044590 |
| 101 | CTCF_21964334_Chip-Seq_Bcells_Human | 1.05866762 |
| 102 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.03929954 |
| 103 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.03603643 |
| 104 | * CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.03586486 |
| 105 | MYB_26560356_Chip-Seq_TH1_Human | 1.02305019 |
| 106 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.02134363 |
| 107 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.02034798 |
| 108 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.01480573 |
| 109 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 1.01253474 |
| 110 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.00965876 |
| 111 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.00705395 |
| 112 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.00502948 |
| 113 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.00090431 |
| 114 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.99886186 |
| 115 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 0.99188348 |
| 116 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.99080031 |
| 117 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 0.99076191 |
| 118 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.98742951 |
| 119 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 0.98740181 |
| 120 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.98736662 |
| 121 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.98565959 |
| 122 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.97728836 |
| 123 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.97567238 |
| 124 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.97567238 |
| 125 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.97263963 |
| 126 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.96459826 |
| 127 | MYB_26560356_Chip-Seq_TH2_Human | 0.95407533 |
| 128 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 0.94085172 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003705_abnormal_hypodermis_morpholog | 4.71344235 |
| 2 | MP0010352_gastrointestinal_tract_polyps | 3.02212147 |
| 3 | MP0010234_abnormal_vibrissa_follicle | 2.99326895 |
| 4 | MP0005076_abnormal_cell_differentiation | 2.84632509 |
| 5 | MP0009840_abnormal_foam_cell | 2.78910503 |
| 6 | MP0009278_abnormal_bone_marrow | 2.73285678 |
| 7 | MP0003300_gastrointestinal_ulcer | 2.72172602 |
| 8 | MP0003303_peritoneal_inflammation | 2.69225417 |
| 9 | MP0005451_abnormal_body_composition | 2.62739652 |
| 10 | MP0003566_abnormal_cell_adhesion | 2.35081786 |
| 11 | MP0005360_urolithiasis | 2.29281852 |
| 12 | MP0008260_abnormal_autophagy | 2.13055571 |
| 13 | MP0008961_abnormal_basal_metabolism | 2.03840144 |
| 14 | MP0002139_abnormal_hepatobiliary_system | 2.00322458 |
| 15 | MP0003724_increased_susceptibility_to | 1.97626368 |
| 16 | MP0003191_abnormal_cellular_cholesterol | 1.97168476 |
| 17 | MP0004185_abnormal_adipocyte_glucose | 1.93482623 |
| 18 | MP0002419_abnormal_innate_immunity | 1.85493418 |
| 19 | MP0005409_darkened_coat_color | 1.78200974 |
| 20 | MP0000685_abnormal_immune_system | 1.73957589 |
| 21 | MP0004510_myositis | 1.70725177 |
| 22 | MP0005025_abnormal_response_to | 1.65863361 |
| 23 | MP0001533_abnormal_skeleton_physiology | 1.65262778 |
| 24 | MP0001849_ear_inflammation | 1.65243730 |
| 25 | MP0001958_emphysema | 1.64497197 |
| 26 | MP0001835_abnormal_antigen_presentation | 1.63946155 |
| 27 | MP0005000_abnormal_immune_tolerance | 1.60290095 |
| 28 | MP0004947_skin_inflammation | 1.58268962 |
| 29 | MP0010307_abnormal_tumor_latency | 1.52329191 |
| 30 | MP0005023_abnormal_wound_healing | 1.49495529 |
| 31 | MP0002998_abnormal_bone_remodeling | 1.49390318 |
| 32 | MP0004858_abnormal_nervous_system | 1.49119720 |
| 33 | MP0001545_abnormal_hematopoietic_system | 1.44135458 |
| 34 | MP0005397_hematopoietic_system_phenotyp | 1.44135458 |
| 35 | MP0005058_abnormal_lysosome_morphology | 1.41787274 |
| 36 | MP0005666_abnormal_adipose_tissue | 1.41243454 |
| 37 | MP0003453_abnormal_keratinocyte_physiol | 1.41235679 |
| 38 | MP0009333_abnormal_splenocyte_physiolog | 1.41012934 |
| 39 | MP0003183_abnormal_peptide_metabolism | 1.39073081 |
| 40 | MP0006082_CNS_inflammation | 1.38105380 |
| 41 | MP0005083_abnormal_biliary_tract | 1.37749741 |
| 42 | MP0004130_abnormal_muscle_cell | 1.37051591 |
| 43 | MP0005365_abnormal_bile_salt | 1.31446199 |
| 44 | MP0003763_abnormal_thymus_physiology | 1.31081358 |
| 45 | MP0005257_abnormal_intraocular_pressure | 1.30782933 |
| 46 | MP0000609_abnormal_liver_physiology | 1.30523823 |
| 47 | MP0003436_decreased_susceptibility_to | 1.29985534 |
| 48 | MP0002723_abnormal_immune_serum | 1.28106688 |
| 49 | MP0002420_abnormal_adaptive_immunity | 1.25574964 |
| 50 | MP0002877_abnormal_melanocyte_morpholog | 1.25560066 |
| 51 | MP0001819_abnormal_immune_cell | 1.25080404 |
| 52 | MP0010329_abnormal_lipoprotein_level | 1.22288107 |
| 53 | MP0000767_abnormal_smooth_muscle | 1.21593016 |
| 54 | MP0002796_impaired_skin_barrier | 1.19747526 |
| 55 | MP0003690_abnormal_glial_cell | 1.18050312 |
| 56 | MP0002148_abnormal_hypersensitivity_rea | 1.18045137 |
| 57 | MP0008438_abnormal_cutaneous_collagen | 1.18034193 |
| 58 | MP0005085_abnormal_gallbladder_physiolo | 1.17192405 |
| 59 | MP0005375_adipose_tissue_phenotype | 1.16380817 |
| 60 | MP0002254_reproductive_system_inflammat | 1.15040757 |
| 61 | MP0000678_abnormal_parathyroid_gland | 1.14729216 |
| 62 | MP0002933_joint_inflammation | 1.13839918 |
| 63 | MP0003252_abnormal_bile_duct | 1.12659258 |
| 64 | MP0009785_altered_susceptibility_to | 1.11194647 |
| 65 | MP0004381_abnormal_hair_follicle | 1.10750231 |
| 66 | MP0000604_amyloidosis | 1.09861222 |
| 67 | MP0003172_abnormal_lysosome_physiology | 1.08300884 |
| 68 | MP0003091_abnormal_cell_migration | 1.08080771 |
| 69 | MP0001730_embryonic_growth_arrest | 1.07313442 |
| 70 | MP0008004_abnormal_stomach_pH | 1.06399928 |
| 71 | MP0005390_skeleton_phenotype | 1.04977874 |
| 72 | MP0010630_abnormal_cardiac_muscle | 1.04628681 |
| 73 | MP0004808_abnormal_hematopoietic_stem | 1.03125013 |
| 74 | MP0000733_abnormal_muscle_development | 1.02163605 |
| 75 | MP0002086_abnormal_extraembryonic_tissu | 0.99722316 |
| 76 | MP0005623_abnormal_meninges_morphology | 0.99469754 |
| 77 | MP0002138_abnormal_hepatobiliary_system | 0.99442199 |
| 78 | MP0005464_abnormal_platelet_physiology | 0.99407710 |
| 79 | MP0003828_pulmonary_edema | 0.98149170 |
| 80 | MP0004087_abnormal_muscle_fiber | 0.97236505 |
| 81 | MP0006054_spinal_hemorrhage | 0.96824421 |
| 82 | MP0005275_abnormal_skin_tensile | 0.96252480 |
| 83 | MP0003075_altered_response_to | 0.93976286 |
| 84 | MP0001348_abnormal_lacrimal_gland | 0.93918529 |
| 85 | MP0005501_abnormal_skin_physiology | 0.93274824 |
| 86 | MP0003656_abnormal_erythrocyte_physiolo | 0.92939660 |
| 87 | MP0004197_abnormal_fetal_growth/weight/ | 0.92897455 |
| 88 | MP0001800_abnormal_humoral_immune | 0.92762231 |
| 89 | MP0000716_abnormal_immune_system | 0.92485177 |
| 90 | MP0001845_abnormal_inflammatory_respons | 0.92336861 |
| 91 | MP0002089_abnormal_postnatal_growth/wei | 0.91656760 |
| 92 | MP0000343_altered_response_to | 0.91439364 |
| 93 | MP0001915_intracranial_hemorrhage | 0.90445628 |
| 94 | MP0002060_abnormal_skin_morphology | 0.90258959 |
| 95 | MP0002269_muscular_atrophy | 0.89339473 |
| 96 | MP0000598_abnormal_liver_morphology | 0.88779385 |
| 97 | MP0002398_abnormal_bone_marrow | 0.88121443 |
| 98 | MP0008874_decreased_physiological_sensi | 0.87995785 |
| 99 | MP0004233_abnormal_muscle_weight | 0.87707266 |
| 100 | MP0001790_abnormal_immune_system | 0.87512362 |
| 101 | MP0005387_immune_system_phenotype | 0.87512362 |
| 102 | MP0008770_decreased_survivor_rate | 0.86825040 |
| 103 | MP0000747_muscle_weakness | 0.86690337 |
| 104 | MP0005166_decreased_susceptibility_to | 0.86604411 |
| 105 | MP0002249_abnormal_larynx_morphology | 0.86572031 |
| 106 | MP0005319_abnormal_enzyme/_coenzyme | 0.86230528 |
| 107 | MP0003045_fibrosis | 0.85437004 |
| 108 | MP0001851_eye_inflammation | 0.85389362 |
| 109 | MP0005167_abnormal_blood-brain_barrier | 0.85319379 |
| 110 | MP0003634_abnormal_glial_cell | 0.85111283 |
| 111 | MP0002088_abnormal_embryonic_growth/wei | 0.83460161 |
| 112 | MP0003984_embryonic_growth_retardation | 0.83201027 |
| 113 | MP0008469_abnormal_protein_level | 0.82460610 |
| 114 | MP0002722_abnormal_immune_system | 0.82362644 |
| 115 | MP0010155_abnormal_intestine_physiology | 0.81416232 |
| 116 | MP0001853_heart_inflammation | 0.81365623 |
| 117 | MP0003279_aneurysm | 0.81017936 |
| 118 | MP0003448_altered_tumor_morphology | 0.80820341 |
| 119 | MP0000689_abnormal_spleen_morphology | 0.80418832 |
| 120 | MP0002084_abnormal_developmental_patter | 0.79531441 |
| 121 | MP0000681_abnormal_thyroid_gland | 0.79497301 |
| 122 | MP0000003_abnormal_adipose_tissue | 0.78875885 |
| 123 | MP0000350_abnormal_cell_proliferation | 0.78384214 |
| 124 | MP0001672_abnormal_embryogenesis/_devel | 0.78081543 |
| 125 | MP0005380_embryogenesis_phenotype | 0.78081543 |
| 126 | MP0005671_abnormal_response_to | 0.77719599 |
| 127 | MP0001216_abnormal_epidermal_layer | 0.77482168 |
| 128 | MP0005310_abnormal_salivary_gland | 0.77362594 |
| 129 | MP0003329_amyloid_beta_deposits | 0.77266284 |
| 130 | MP0002080_prenatal_lethality | 0.77089781 |
| 131 | MP0002896_abnormal_bone_mineralization | 0.76484721 |
| 132 | MP0003795_abnormal_bone_structure | 0.76393097 |
| 133 | MP0000750_abnormal_muscle_regeneration | 0.76239024 |
| 134 | MP0001666_abnormal_nutrient_absorption | 0.75944883 |
| 135 | MP0002653_abnormal_ependyma_morphology | 0.75810703 |
| 136 | MP0002429_abnormal_blood_cell | 0.75582037 |
| 137 | MP0009931_abnormal_skin_appearance | 0.75385544 |
| 138 | MP0002452_abnormal_antigen_presenting | 0.75000869 |
| 139 | MP0001873_stomach_inflammation | 0.74624368 |
| 140 | MP0005670_abnormal_white_adipose | 0.74380494 |
| 141 | MP0001697_abnormal_embryo_size | 0.74217452 |
| 142 | MP0002925_abnormal_cardiovascular_devel | 0.74159840 |
| 143 | MP0002405_respiratory_system_inflammati | 0.73877790 |
| 144 | MP0000751_myopathy | 0.73471259 |
| 145 | MP0005410_abnormal_fertilization | 0.72776920 |
| 146 | MP0000858_altered_metastatic_potential | 0.72024991 |
| 147 | MP0002166_altered_tumor_susceptibility | 0.71075577 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Cerebral aneurysm (HP:0004944) | 3.75471493 |
| 2 | Eczematoid dermatitis (HP:0000976) | 3.47418090 |
| 3 | Nasal polyposis (HP:0100582) | 3.41020480 |
| 4 | Obstructive sleep apnea (HP:0002870) | 3.34223972 |
| 5 | Abnormality of the nasal mucosa (HP:0000433) | 3.30147918 |
| 6 | Dysostosis multiplex (HP:0000943) | 3.22858751 |
| 7 | Hyperacusis (HP:0010780) | 3.21526636 |
| 8 | Ulnar bowing (HP:0003031) | 2.94760118 |
| 9 | Achilles tendon contracture (HP:0001771) | 2.88242125 |
| 10 | Abnormality of the Achilles tendon (HP:0005109) | 2.88062152 |
| 11 | Abnormality of macrophages (HP:0004311) | 2.83525782 |
| 12 | Deep venous thrombosis (HP:0002625) | 2.81344582 |
| 13 | Upper limb amyotrophy (HP:0009129) | 2.80837007 |
| 14 | Distal upper limb amyotrophy (HP:0007149) | 2.80837007 |
| 15 | Recurrent bacterial skin infections (HP:0005406) | 2.78970465 |
| 16 | Thin bony cortex (HP:0002753) | 2.78290880 |
| 17 | Abnormality of the lower motor neuron (HP:0002366) | 2.73064489 |
| 18 | Hand muscle atrophy (HP:0009130) | 2.72227386 |
| 19 | Recurrent abscess formation (HP:0002722) | 2.70731488 |
| 20 | Cervical subluxation (HP:0003308) | 2.70277896 |
| 21 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.69525217 |
| 22 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.69525217 |
| 23 | Abnormality of glycolipid metabolism (HP:0010969) | 2.69525217 |
| 24 | Neurofibrillary tangles (HP:0002185) | 2.69284866 |
| 25 | Mucopolysacchariduria (HP:0008155) | 2.68767384 |
| 26 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.68767384 |
| 27 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.65986187 |
| 28 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.65986187 |
| 29 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.65986187 |
| 30 | Difficulty climbing stairs (HP:0003551) | 2.64496507 |
| 31 | Vertebral compression fractures (HP:0002953) | 2.62397628 |
| 32 | Broad face (HP:0000283) | 2.60650673 |
| 33 | Polycythemia (HP:0001901) | 2.54049944 |
| 34 | Increased connective tissue (HP:0009025) | 2.53448696 |
| 35 | Shallow orbits (HP:0000586) | 2.49263973 |
| 36 | Protrusio acetabuli (HP:0003179) | 2.46391013 |
| 37 | Reticulocytosis (HP:0001923) | 2.32534447 |
| 38 | Myositis (HP:0100614) | 2.30959295 |
| 39 | Xanthomatosis (HP:0000991) | 2.28825883 |
| 40 | Gingivitis (HP:0000230) | 2.27086190 |
| 41 | Aneurysm (HP:0002617) | 2.25692176 |
| 42 | J-shaped sella turcica (HP:0002680) | 2.22112482 |
| 43 | Hematochezia (HP:0002573) | 2.20625500 |
| 44 | Global brain atrophy (HP:0002283) | 2.19788865 |
| 45 | Mitral valve prolapse (HP:0001634) | 2.18690304 |
| 46 | Difficulty running (HP:0009046) | 2.18278976 |
| 47 | Asymmetric septal hypertrophy (HP:0001670) | 2.17862603 |
| 48 | Peritonitis (HP:0002586) | 2.17679723 |
| 49 | Increased density of long bones (HP:0006392) | 2.17526686 |
| 50 | Insomnia (HP:0100785) | 2.16053515 |
| 51 | Hyporeflexia of lower limbs (HP:0002600) | 2.15967336 |
| 52 | Orchitis (HP:0100796) | 2.15132211 |
| 53 | Turricephaly (HP:0000262) | 2.12795408 |
| 54 | Amyloidosis (HP:0011034) | 2.11692471 |
| 55 | Papilloma (HP:0012740) | 2.10545493 |
| 56 | Verrucae (HP:0200043) | 2.10545493 |
| 57 | Back pain (HP:0003418) | 2.10452129 |
| 58 | Myocardial infarction (HP:0001658) | 2.10374726 |
| 59 | Lymphangioma (HP:0100764) | 2.08926959 |
| 60 | Colitis (HP:0002583) | 2.08490780 |
| 61 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.07927697 |
| 62 | Ependymoma (HP:0002888) | 2.06670571 |
| 63 | Cellulitis (HP:0100658) | 2.06612322 |
| 64 | Chronic otitis media (HP:0000389) | 2.05292068 |
| 65 | Supranuclear gaze palsy (HP:0000605) | 2.05034317 |
| 66 | Nuclear cataract (HP:0100018) | 2.04986953 |
| 67 | Distal lower limb muscle weakness (HP:0009053) | 2.04553266 |
| 68 | Axonal loss (HP:0003447) | 2.04531508 |
| 69 | Joint stiffness (HP:0001387) | 2.04271101 |
| 70 | Increased variability in muscle fiber diameter (HP:0003557) | 2.02940405 |
| 71 | Spastic diplegia (HP:0001264) | 2.02925098 |
| 72 | Neuronal loss in central nervous system (HP:0002529) | 2.02880428 |
| 73 | Macroorchidism (HP:0000053) | 2.02121042 |
| 74 | Long toe (HP:0010511) | 2.01976922 |
| 75 | Flat acetabular roof (HP:0003180) | 2.01937872 |
| 76 | Fibroma (HP:0010614) | 2.01663975 |
| 77 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.01419769 |
| 78 | Increased IgE level (HP:0003212) | 1.99929676 |
| 79 | Spontaneous hematomas (HP:0007420) | 1.99110264 |
| 80 | Bowing of the arm (HP:0006488) | 1.98982255 |
| 81 | Bowed forearm bones (HP:0003956) | 1.98982255 |
| 82 | Emphysema (HP:0002097) | 1.97385242 |
| 83 | Mitral regurgitation (HP:0001653) | 1.97001465 |
| 84 | Autoimmune thrombocytopenia (HP:0001973) | 1.96698841 |
| 85 | Multiple enchondromatosis (HP:0005701) | 1.96467516 |
| 86 | Systemic lupus erythematosus (HP:0002725) | 1.94354583 |
| 87 | Aortic aneurysm (HP:0004942) | 1.93514391 |
| 88 | Purpura (HP:0000979) | 1.93338317 |
| 89 | Interstitial pulmonary disease (HP:0006530) | 1.92341561 |
| 90 | Mediastinal lymphadenopathy (HP:0100721) | 1.91424582 |
| 91 | Increased cerebral lipofuscin (HP:0011813) | 1.90505609 |
| 92 | Elfin facies (HP:0004428) | 1.90466967 |
| 93 | Enlarged penis (HP:0000040) | 1.90430817 |
| 94 | Subacute progressive viral hepatitis (HP:0006572) | 1.90386557 |
| 95 | Fibrous tissue neoplasm (HP:0012316) | 1.90208916 |
| 96 | Biconcave vertebral bodies (HP:0004586) | 1.89935841 |
| 97 | Ankle contracture (HP:0006466) | 1.89710460 |
| 98 | Genu recurvatum (HP:0002816) | 1.87571655 |
| 99 | Obstructive lung disease (HP:0006536) | 1.87217882 |
| 100 | Chronic obstructive pulmonary disease (HP:0006510) | 1.87217882 |
| 101 | Gastrointestinal inflammation (HP:0004386) | 1.86839255 |
| 102 | Broad metatarsal (HP:0001783) | 1.85689495 |
| 103 | Polygenic inheritance (HP:0010982) | 1.84513464 |
| 104 | Abnormality of the thoracic spine (HP:0100711) | 1.84024537 |
| 105 | Fragile skin (HP:0001030) | 1.83330352 |
| 106 | Gastrointestinal infarctions (HP:0005244) | 1.83257396 |
| 107 | Esophageal varix (HP:0002040) | 1.82468168 |
| 108 | Pseudobulbar signs (HP:0002200) | 1.80763223 |
| 109 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.78761916 |
| 110 | Distal lower limb amyotrophy (HP:0008944) | 1.78631642 |
| 111 | Angiofibromas (HP:0010615) | 1.78588112 |
| 112 | Adenoma sebaceum (HP:0009720) | 1.78588112 |
| 113 | Dysmetric saccades (HP:0000641) | 1.77174155 |
| 114 | Asymmetry of the thorax (HP:0001555) | 1.76922580 |
| 115 | Basal cell carcinoma (HP:0002671) | 1.76634123 |
| 116 | Frequent falls (HP:0002359) | 1.75840190 |
| 117 | EMG: neuropathic changes (HP:0003445) | 1.75822177 |
| 118 | Renovascular hypertension (HP:0100817) | 1.75779324 |
| 119 | Cerebral inclusion bodies (HP:0100314) | 1.75548742 |
| 120 | Myoglobinuria (HP:0002913) | 1.75191870 |
| 121 | Heterotopia (HP:0002282) | 1.74513606 |
| 122 | Dilatation of the ascending aorta (HP:0005111) | 1.74354153 |
| 123 | Renal duplication (HP:0000075) | 1.74254524 |
| 124 | Increased CSF protein (HP:0002922) | 1.73329210 |
| 125 | Arterial tortuosity (HP:0005116) | 1.72991746 |
| 126 | Blue sclerae (HP:0000592) | 1.72696518 |
| 127 | Hypercortisolism (HP:0001578) | 1.72394917 |
| 128 | Increased mean platelet volume (HP:0011877) | 1.72385960 |
| 129 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.72186950 |
| 130 | Abnormal platelet volume (HP:0011876) | 1.72054544 |
| 131 | Right ventricular cardiomyopathy (HP:0011663) | 1.72031421 |
| 132 | Inflammation of the large intestine (HP:0002037) | 1.70624561 |
| 133 | Pustule (HP:0200039) | 1.69812451 |
| 134 | Hyperparathyroidism (HP:0000843) | 1.68744179 |
| 135 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.68566418 |
| 136 | Vascular tortuosity (HP:0004948) | 1.66803400 |
| 137 | Bladder diverticulum (HP:0000015) | 1.66426077 |
| 138 | Spinal cord lesions (HP:0100561) | 1.65591132 |
| 139 | Syringomyelia (HP:0003396) | 1.65591132 |
| 140 | Hypochromic anemia (HP:0001931) | 1.65513092 |
| 141 | Stridor (HP:0010307) | 1.65444578 |
| 142 | Visceral angiomatosis (HP:0100761) | 1.65166352 |
| 143 | Astrocytoma (HP:0009592) | 1.64433660 |
| 144 | Abnormality of the astrocytes (HP:0100707) | 1.64433660 |
| 145 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.63982516 |
| 146 | Abnormality of complement system (HP:0005339) | 1.63908506 |
| 147 | Hypertensive crisis (HP:0100735) | 1.63437488 |
| 148 | Recurrent skin infections (HP:0001581) | 1.63216967 |
| 149 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.62797578 |
| 150 | Pointed chin (HP:0000307) | 1.62775805 |
| 151 | Thoracic kyphosis (HP:0002942) | 1.62705653 |
| 152 | Metaphyseal cupping (HP:0003021) | 1.62678909 |
| 153 | Disproportionate tall stature (HP:0001519) | 1.62556675 |
| 154 | Optic neuritis (HP:0100653) | 1.62479189 |
| 155 | Retrobulbar optic neuritis (HP:0100654) | 1.62479189 |
| 156 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.62340642 |
| 157 | Deformed sella turcica (HP:0002681) | 1.62292681 |
| 158 | Bowel diverticulosis (HP:0005222) | 1.62195673 |
| 159 | Bone pain (HP:0002653) | 1.61959945 |
| 160 | Prolonged bleeding time (HP:0003010) | 1.61325260 |
| 161 | Hemorrhage of the eye (HP:0011885) | 1.61081280 |
| 162 | Premature rupture of membranes (HP:0001788) | 1.60821761 |
| 163 | Rapidly progressive (HP:0003678) | 1.60627638 |
| 164 | Spondylolisthesis (HP:0003302) | 1.60339255 |
| 165 | Hypercholesterolemia (HP:0003124) | 1.60055965 |
| 166 | Loss of speech (HP:0002371) | 1.58654604 |
| 167 | Hemangiomatosis (HP:0007461) | 1.58544048 |
| 168 | Gastrointestinal stroma tumor (HP:0100723) | 1.58093330 |
| 169 | Overriding aorta (HP:0002623) | 1.56971508 |
| 170 | Rectal prolapse (HP:0002035) | 1.56474480 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TRIB3 | 4.83511101 |
| 2 | MAP3K10 | 4.20906241 |
| 3 | PKN2 | 3.97126061 |
| 4 | PRPF4B | 3.49750840 |
| 5 | EEF2K | 3.39781658 |
| 6 | ERN1 | 3.16301767 |
| 7 | ICK | 2.58691206 |
| 8 | RIPK4 | 2.40222067 |
| 9 | IRAK3 | 2.29447889 |
| 10 | PTK6 | 2.14098557 |
| 11 | CDK12 | 1.99832250 |
| 12 | SMG1 | 1.98804218 |
| 13 | TTN | 1.97252220 |
| 14 | RIPK1 | 1.97248470 |
| 15 | GRK6 | 1.88647546 |
| 16 | MAP4K1 | 1.87364500 |
| 17 | MAP3K13 | 1.81280476 |
| 18 | STK10 | 1.74276671 |
| 19 | LRRK2 | 1.71322417 |
| 20 | SIK1 | 1.60667864 |
| 21 | MARK2 | 1.48606998 |
| 22 | BLK | 1.47895479 |
| 23 | PRKD3 | 1.46302960 |
| 24 | IRAK2 | 1.42242156 |
| 25 | PDGFRA | 1.42169905 |
| 26 | EPHB1 | 1.40146759 |
| 27 | TAOK2 | 1.38985425 |
| 28 | NEK2 | 1.38317897 |
| 29 | BMX | 1.37610760 |
| 30 | TYRO3 | 1.35103790 |
| 31 | NME2 | 1.33305587 |
| 32 | SCYL2 | 1.30285314 |
| 33 | TNK2 | 1.29235112 |
| 34 | ALK | 1.28609326 |
| 35 | PAK4 | 1.26896259 |
| 36 | IRAK4 | 1.25483808 |
| 37 | MAP3K14 | 1.24714008 |
| 38 | TAOK1 | 1.19666622 |
| 39 | FGFR4 | 1.18733637 |
| 40 | TESK1 | 1.17840763 |
| 41 | CDC42BPA | 1.15635149 |
| 42 | KSR2 | 1.13688981 |
| 43 | EPHA2 | 1.07876273 |
| 44 | ARAF | 1.05641666 |
| 45 | MTOR | 1.03828394 |
| 46 | CDK6 | 0.96688777 |
| 47 | TYK2 | 0.96166282 |
| 48 | RET | 0.95716000 |
| 49 | MAP3K11 | 0.95622400 |
| 50 | MAP3K8 | 0.91179428 |
| 51 | PDK3 | 0.90428541 |
| 52 | PDK4 | 0.90428541 |
| 53 | MAP2K3 | 0.89937919 |
| 54 | DYRK1B | 0.89541272 |
| 55 | TGFBR2 | 0.89394217 |
| 56 | MAP3K6 | 0.88586582 |
| 57 | PTK2 | 0.87693864 |
| 58 | SIK2 | 0.87604024 |
| 59 | SIK3 | 0.87368603 |
| 60 | DDR2 | 0.85131754 |
| 61 | STK3 | 0.84723218 |
| 62 | MAPK12 | 0.84333740 |
| 63 | TBK1 | 0.84099915 |
| 64 | MAP3K9 | 0.83376098 |
| 65 | CSK | 0.80738899 |
| 66 | PAK2 | 0.78871858 |
| 67 | FES | 0.78404836 |
| 68 | FLT3 | 0.78336611 |
| 69 | LATS2 | 0.77062831 |
| 70 | MAPKAPK3 | 0.76987187 |
| 71 | MAP3K7 | 0.76905397 |
| 72 | NTRK1 | 0.76723438 |
| 73 | CDK4 | 0.76092982 |
| 74 | MAPK7 | 0.73189015 |
| 75 | MATK | 0.72859087 |
| 76 | JAK2 | 0.72749895 |
| 77 | HIPK2 | 0.72628018 |
| 78 | MAP3K2 | 0.71816508 |
| 79 | CAMKK1 | 0.71121428 |
| 80 | ZAP70 | 0.70233464 |
| 81 | CAMK1D | 0.70022539 |
| 82 | RPS6KA4 | 0.67523003 |
| 83 | IKBKE | 0.67470646 |
| 84 | PDGFRB | 0.66467845 |
| 85 | STK4 | 0.65146303 |
| 86 | PRKCH | 0.65142146 |
| 87 | CAMK1G | 0.64829033 |
| 88 | IRAK1 | 0.64273357 |
| 89 | PIM1 | 0.62817875 |
| 90 | JAK1 | 0.62606646 |
| 91 | MOS | 0.61530454 |
| 92 | NEK1 | 0.60434512 |
| 93 | RPS6KB2 | 0.59758624 |
| 94 | HCK | 0.57624131 |
| 95 | CSF1R | 0.56968348 |
| 96 | SGK3 | 0.56510679 |
| 97 | MAPK11 | 0.56354505 |
| 98 | DMPK | 0.55466821 |
| 99 | RPS6KA1 | 0.54937196 |
| 100 | IKBKB | 0.53823628 |
| 101 | MAP3K3 | 0.52517404 |
| 102 | PDK1 | 0.52272327 |
| 103 | PRKD2 | 0.52152363 |
| 104 | FGFR3 | 0.49975117 |
| 105 | JAK3 | 0.49950474 |
| 106 | MAP3K1 | 0.48302545 |
| 107 | TESK2 | 0.47928614 |
| 108 | PTK2B | 0.47513426 |
| 109 | PRKD1 | 0.47305308 |
| 110 | PIM2 | 0.47296829 |
| 111 | DAPK2 | 0.47208766 |
| 112 | BTK | 0.47171588 |
| 113 | EGFR | 0.46627000 |
| 114 | PRKG2 | 0.45720574 |
| 115 | SYK | 0.45344329 |
| 116 | RPS6KA2 | 0.45146189 |
| 117 | CHUK | 0.44763657 |
| 118 | STK11 | 0.43298576 |
| 119 | LMTK2 | 0.42829812 |
| 120 | MAP2K2 | 0.42192684 |
| 121 | FGR | 0.41831255 |
| 122 | PAK6 | 0.41431395 |
| 123 | MAPK4 | 0.39122671 |
| 124 | PDPK1 | 0.38929132 |
| 125 | RPS6KC1 | 0.38574374 |
| 126 | RPS6KL1 | 0.38574374 |
| 127 | BRAF | 0.38318946 |
| 128 | BCKDK | 0.37871793 |
| 129 | FGFR1 | 0.36360580 |
| 130 | ILK | 0.36232374 |
| 131 | RPS6KA6 | 0.35401770 |
| 132 | GSK3A | 0.35371964 |
| 133 | STK38 | 0.35212054 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.90860230 |
| 2 | Other glycan degradation_Homo sapiens_hsa00511 | 2.65360008 |
| 3 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.44243917 |
| 4 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.89385859 |
| 5 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.66012454 |
| 6 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.65142194 |
| 7 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.61643428 |
| 8 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.60419838 |
| 9 | Insulin resistance_Homo sapiens_hsa04931 | 1.55638935 |
| 10 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.54841863 |
| 11 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.54086147 |
| 12 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.51589326 |
| 13 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 1.46539053 |
| 14 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.43562144 |
| 15 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.43528677 |
| 16 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.41467878 |
| 17 | Lysosome_Homo sapiens_hsa04142 | 1.39582382 |
| 18 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.37669952 |
| 19 | Lysine degradation_Homo sapiens_hsa00310 | 1.33261769 |
| 20 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.31729250 |
| 21 | Bladder cancer_Homo sapiens_hsa05219 | 1.25725730 |
| 22 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.22301659 |
| 23 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.20697305 |
| 24 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.19949111 |
| 25 | Malaria_Homo sapiens_hsa05144 | 1.19495907 |
| 26 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.19413813 |
| 27 | Bile secretion_Homo sapiens_hsa04976 | 1.18203935 |
| 28 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.17892839 |
| 29 | AMPK signaling pathway_Homo sapiens_hsa04152 | 1.17860222 |
| 30 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.15590145 |
| 31 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.14963927 |
| 32 | Hepatitis C_Homo sapiens_hsa05160 | 1.12336068 |
| 33 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.12031139 |
| 34 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.11444709 |
| 35 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.10505934 |
| 36 | Influenza A_Homo sapiens_hsa05164 | 1.10157233 |
| 37 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.09512466 |
| 38 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.08669552 |
| 39 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.08594494 |
| 40 | Prion diseases_Homo sapiens_hsa05020 | 1.06954704 |
| 41 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.06918581 |
| 42 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.06589510 |
| 43 | Insulin signaling pathway_Homo sapiens_hsa04910 | 1.06437540 |
| 44 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.06210046 |
| 45 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.06090249 |
| 46 | Glioma_Homo sapiens_hsa05214 | 1.05948652 |
| 47 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.04699856 |
| 48 | Endometrial cancer_Homo sapiens_hsa05213 | 1.04571700 |
| 49 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.03632958 |
| 50 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.03245363 |
| 51 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.02323564 |
| 52 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.01497177 |
| 53 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.01352587 |
| 54 | Adherens junction_Homo sapiens_hsa04520 | 1.00848864 |
| 55 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.00431878 |
| 56 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.99770701 |
| 57 | Focal adhesion_Homo sapiens_hsa04510 | 0.98903777 |
| 58 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.97909874 |
| 59 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.97833330 |
| 60 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.97159282 |
| 61 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.96667906 |
| 62 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.96288030 |
| 63 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.95798431 |
| 64 | Pertussis_Homo sapiens_hsa05133 | 0.95385913 |
| 65 | Allograft rejection_Homo sapiens_hsa05330 | 0.95214376 |
| 66 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.94090053 |
| 67 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.92491146 |
| 68 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.92295292 |
| 69 | Carbon metabolism_Homo sapiens_hsa01200 | 0.91333550 |
| 70 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.89777149 |
| 71 | Salmonella infection_Homo sapiens_hsa05132 | 0.89714229 |
| 72 | Amoebiasis_Homo sapiens_hsa05146 | 0.89564460 |
| 73 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.88964662 |
| 74 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.88936872 |
| 75 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.87894648 |
| 76 | Apoptosis_Homo sapiens_hsa04210 | 0.87675990 |
| 77 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.86973829 |
| 78 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.86749020 |
| 79 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.86559303 |
| 80 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.81790673 |
| 81 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.81787095 |
| 82 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.81428503 |
| 83 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.81393042 |
| 84 | Phagosome_Homo sapiens_hsa04145 | 0.81273588 |
| 85 | Platelet activation_Homo sapiens_hsa04611 | 0.80962776 |
| 86 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.80805476 |
| 87 | Measles_Homo sapiens_hsa05162 | 0.80445319 |
| 88 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.80126466 |
| 89 | Colorectal cancer_Homo sapiens_hsa05210 | 0.79618458 |
| 90 | Viral myocarditis_Homo sapiens_hsa05416 | 0.78763268 |
| 91 | Leishmaniasis_Homo sapiens_hsa05140 | 0.77268489 |
| 92 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.76939567 |
| 93 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.76703539 |
| 94 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.76003831 |
| 95 | Endocytosis_Homo sapiens_hsa04144 | 0.75490013 |
| 96 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.75400079 |
| 97 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.74956528 |
| 98 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.73694670 |
| 99 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.73514532 |
| 100 | Prostate cancer_Homo sapiens_hsa05215 | 0.73461733 |
| 101 | Shigellosis_Homo sapiens_hsa05131 | 0.72122892 |
| 102 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.71838709 |
| 103 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.71249213 |
| 104 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.70552508 |
| 105 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.69214431 |
| 106 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.67656318 |
| 107 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.67285278 |
| 108 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.67019907 |
| 109 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.66832214 |
| 110 | Sulfur relay system_Homo sapiens_hsa04122 | 0.66704313 |
| 111 | Hepatitis B_Homo sapiens_hsa05161 | 0.65836839 |
| 112 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.65544090 |
| 113 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.65176530 |
| 114 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.63652220 |
| 115 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.63212328 |
| 116 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.61180238 |
| 117 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.60964224 |
| 118 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.59942437 |
| 119 | ABC transporters_Homo sapiens_hsa02010 | 0.59716650 |
| 120 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.59203859 |
| 121 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.59169622 |
| 122 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.58710217 |
| 123 | HTLV-I infection_Homo sapiens_hsa05166 | 0.58649408 |
| 124 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.58631081 |
| 125 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.58576862 |
| 126 | Thyroid cancer_Homo sapiens_hsa05216 | 0.58052837 |
| 127 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.57958487 |
| 128 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.57455516 |
| 129 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.56895088 |
| 130 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.56537271 |
| 131 | Long-term potentiation_Homo sapiens_hsa04720 | 0.54766154 |
| 132 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.53912604 |
| 133 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.53483312 |
| 134 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.53289679 |
| 135 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.52068169 |
| 136 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.52040357 |
| 137 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.51548834 |
| 138 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.51335048 |
| 139 | Tuberculosis_Homo sapiens_hsa05152 | 0.51325362 |
| 140 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.49059934 |
| 141 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.47486346 |

